Strongest Adderall Alternative 2026: NeuroXen Report Maps OTC “Adderall Alternative” Search Behavior and a 5-Point Verification Framework
Pacific Palisades, California, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article…
Strongest Phentermine Alternatives 2026: What OTC Options Actually Exist? Phen24 Consumer Search Analysis and 7-Point Verification Framework
Los Angeles, California, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article…
Liberation Bioindustries Announces New Roles for Founders
RICHMOND, Ind., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Liberation Bioindustries announces its…
Ascentage Pharma Outlined its Global Innovation Strategy During Presentation at 44th Annual J.P. Morgan Healthcare Conference
Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong…
Psyence BioMed Announces Effective Date for 1-for-6.25 Reverse Stock Split
NEW YORK, Jan. 14, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq:…
New site in Lommel, Belgium: Aqua free successfully completes set-up phase with ISO 9001 certification
Lommel / Hamburg, 01/15/2026 – Aqua free, a leading provider of innovative drinking-water…
Inside information: Orion provides outlook for 2026 and estimates that the annual Nubeqa net sales recorded by Orion has potential to exceed EUR 1 billion in the future
January 14, 2026 01:30 ET | Source: Orion Oyj ORION CORPORATION STOCK EXCHANGE…
New data reinforces Ipsens commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS
14 abstracts will be presented across a range of neurological conditions including…
HUTCHMED Highlights Publication of Phase III SACHI Results in The Lancet
— First randomized Phase III trial confirming the efficacy of MET inhibition…
